S100A12 decreased SAA-induced ERK1/2 and MEK1/2 phosphorylation. by Yuen Ming Chung (406571)

SAA and saaHDL decrease adiponectin secretion by hMADS adipocytes. by Aurélie Faty (169741)

Gal 3/LPS interaction decreases mice resistance to the lethality of LPS. by Marise Lopes Fermino (341245)

Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

“…Average integrated density (% control) was determined in a region of interest in the dorsolateral striatum in mice (n = 5−8 sacrificed 48 hours (I) or 6 days (J) after the last METH injection. …”

Expression of PON1 decreases superoxide levels in germ-free <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…Untreated controls showed no differences at any time, and are combined as a single group in each graph (N = 23). Maximum actomyosin MgATPase activity tended to decrease following PPT treatment, but did not reach statistical significance. …”

MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

“…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”

Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Effect of different doses (mg/Kg) of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on serum ALT and AST levels. Data represented as mea... by Fatma A. Moharram (9276104)

Dysfunction of <i>ERG251</i> activates a Zinc transporter contributing to decreased azole susceptibility. by Xin Zhou (54275)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…<p>(<b>A</b>) N100 amplitude reduction during 1 Hz-rTMS (group mean values). …”

PKRA7 decreases subcutaneous and intracranial glioblastoma xenograft tumor growth. by Valerie F. Curtis (276433)

“…<p>(<b>A</b>) D456MG cells were SC injected into nude mice, and control (n = 5) or PKRA7 (n = 5) treatment was commenced when tumors became visually detectable (14 days). …”

RES decreases mitochondrial ROS production in ethanol-fed rat livers. by Zhenhua Ma (4344910)

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates. by Alexandra Anderson (97972)

“…<p>Adult wild type animals were exposed to <i>M. nematophilum</i> on plates containing exogenous serotonin and the Dar phenotype was scored in their progeny. Treatment with 3.8 mg/ml 5-HT caused a 35% decrease in the number of Dar animals following <i>M. nematophilum</i> infection using standard assay conditions (small lawn) (A). …”

Erythrocyte membrane beta-actin band decrease intensities in RTT patients. by Alessio Cortelazzo (543292)

General patient characteristics. by Ekaterina A. Bryushkova (13360122)

Subjects: